Back to the Top
Is bioequivalence data sufficient for DCGI approval for leuprolide
depot formulation in the new drug category?
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Bioequivalence leuprolide depot formulation" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (email@example.com)